Are Research Peptides Australia and Brain Skin Bioregulators effective for cognitive wellness?

Spexin: The Newly Identified Peptide for Metabolic and Appetite Research

September 26, 2026 infa sense

Why did researchers become interested in Spexin?

The problem: Many metabolic hormones were discovered by isolating substances from tissues or blood and then testing their effects. That traditional process can be slow, especially when a peptide is present in very small quantities.

The research response: Spexin was identified through bioinformatics, the use of computer analysis to examine genetic and protein sequences. Researchers searched genomic data for a previously unrecognised peptide that might belong to the galanin family. Later laboratory work supported its existence as an endogenous signalling molecule.

This is similar to finding a missing component in a digital blueprint before locating the physical part in a machine. The computer model suggested that the peptide should exist; biochemical and physiological studies then helped investigate what it does.

Spexin was subsequently identified as an endogenous ligand for GALR2 and GALR3. “Endogenous” means produced naturally inside the body. A “ligand” is a signalling molecule that binds to a receptor, much like a key fitting into a lock.

The receptor connection

Galanin receptors are cell-surface proteins that help transmit signals between cells. Spexin appears to interact primarily with:

  • GALR2, or galanin receptor 2
  • GALR3, or galanin receptor 3

Spexin does not simply switch one biological process on or off. Its effects may depend on the tissue, receptor, dose, timing and metabolic state being studied. That is why researchers continue to examine whether GALR2, GALR3 or both are most important in different outcomes.

Two neutral research peptide vials photographed with clinical lighting

Spexin and appetite: a possible satiety signal

The problem: Appetite is not controlled by willpower alone. The brain receives a continuous stream of information about stored energy, recent meals, hormones and nutrient availability. When these signals become unbalanced, hunger and food intake can become harder to regulate.

The research response: Experimental studies suggest that Spexin may act as an anorexigenic signal. Anorexigenic means appetite-suppressing. In animal models, Spexin has been associated with:

  • Reduced food intake
  • Changes in meal size and feeding patterns
  • Lower body weight in some diet-induced obesity models
  • Changes in hypothalamic appetite signalling

The hypothalamus works like a central control room. It receives information from the body and helps coordinate hunger, satiety, temperature, sleep and energy use. Research has examined whether Spexin influences appetite-related pathways involving neuropeptide Y (NPY), agouti-related peptide (AgRP) and the ghrelin receptor.

This is especially interesting because ghrelin generally acts as a hunger signal, while Spexin may operate in the opposite direction. You can think of the two systems as opposing pedals in a vehicle: one encourages energy intake, while the other may help apply the brakes.

However, animal findings do not automatically predict human outcomes. The human appetite system is a large network rather than a single switch.

Video placeholder: How Spexin may influence appetite, satiety and hypothalamic signalling